Drug:
Reaction: ASTHMA
20260101 - 20261231
No. 1401 - 1500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1401 | 26726468 |
US |
61 | 1 |
Influenza, Asthma, |
||||
DUPILUMAB, |
||||
| 1402 | 26726690 |
US |
70 | 2 |
Asthma, |
||||
OMALIZUMAB, |
||||
| 1403 | 26726837 |
1 | ||
Anxiety, Therapy non-responder, Asthma, Quality of life decreased, |
||||
MEPOLIZUMAB, ALBUTEROL SULFATE, METHOCARBAMOL, METHOCARBAMOL TABLETS, METHYLPREDNISOLONE, |
||||
| 1404 | 26718303 |
CA |
47 | |
Abdominal pain, Abscess intestinal, Asthenia, Body temperature abnormal, Discomfort, Diverticulitis, Dyspnoea, Dyspnoea exertional, General physical health deterioration, Haematochezia, Hair growth abnormal, Hyperthermia, Increased bronchial secretion, Increased upper airway secretion, Influenza, Irritable bowel syndrome, Mobility decreased, Nail growth abnormal, Nasal congestion, Nasal discharge discolouration, Nasal polyps, Nasopharyngitis, Oropharyngeal pain, Pain, Pollakiuria, Productive cough, Pulmonary congestion, Respiration abnormal, Respiratory tract infection, Rhinorrhoea, Saliva discolouration, Secretion discharge, Sensitive skin, Sleep disorder, Sputum discoloured, Throat clearing, Thyroid disorder, Toothache, Vomiting, Weight decreased, Asthma, Bronchial disorder, Concomitant disease aggravated, Ligament sprain, Sensitivity to weather change, Cough, Diarrhoea, Fatigue, Headache, Myalgia, Nausea, Pyrexia, Inappropriate schedule of product administration, Incorrect dose administered, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 1405 | 26718349 |
CA |
12 | |
Bronchiectasis, Concomitant disease aggravated, Middle insomnia, Obstructive airways disorder, Wheezing, Asthma, Respiratory rate increased, Weight increased, Drug ineffective, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, HYDROCORTISONE, ERGOCALCIFEROL, |
||||
| 1406 | 26718425 |
US |
59 | 2 |
Syncope, Hypothyroidism, Epilepsy, Glucose tolerance impaired, Pyrexia, Chills, Viral upper respiratory tract infection, Alanine aminotransferase increased, Serum ferritin increased, Head injury, Cardiac murmur, Obstructive sleep apnoea syndrome, Iron deficiency anaemia, Stress, Tongue biting, Drug ineffective, Obesity, Gastrooesophageal reflux disease, Illness, Bronchitis, Headache, Disorientation, Hypersensitivity, Weight increased, Cough, Pain, Ageusia, Middle ear effusion, Blood cholesterol increased, Anxiety, Asthma, Vitamin D decreased, Essential hypertension, Tongue biting, |
||||
EVOLOCUMAB, PREDNISONE, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, ICOSAPENT ETHYL, |
||||
| 1407 | 26718499 |
US |
1 | |
Asthenia, Dyspnoea, Asthma, |
||||
RIVAROXABAN, MESALAMINE, BUDESONIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MONTELUKAST, THYROID, IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA,, PANTOPRAZOLE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, EZETIMIBE, |
||||
| 1408 | 26718875 |
US |
36 | 2 |
Asthma, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1409 | 26719042 |
US |
55 | 2 |
Sleep disorder due to a general medical condition, Rash, Discomfort, Asthma, Quality of life decreased, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, AMOXICILLIN, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUPROPION, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, PREDNISOLONE ACETATE, |
||||
| 1410 | 26719099 |
CA |
65 | |
Jaw fracture, Lower respiratory tract infection, Pneumonia, Asthma, Blood immunoglobulin E increased, Dyspnoea, Eye pruritus, Face injury, Forced expiratory volume decreased, General physical condition abnormal, Glycosylated haemoglobin increased, Haematocrit increased, Hyperhidrosis, Influenza, Meniscus injury, Mucosal discolouration, Nasopharyngitis, Neutrophil count increased, Obstructive airways disorder, Red blood cell count increased, Sinus congestion, Sinus disorder, Stress, Tachycardia, Viral infection, Wheezing, White blood cell count decreased, Infection, Sinusitis, Cough, Weight increased, Inappropriate schedule of product administration, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, GLYCOPYRROLATE, VALSARTAN, VALSARTAN ORAL, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, CICLESONIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, DESOXIMETASONE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, PREGABALIN, MEDROXYPROGESTERONE ACETATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, PREDNISONE, PREDNISONE, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, RISEDRONATE SODIUM, RISEDRONATE SODIUM, ROSUVASTATIN, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 1411 | 26719104 |
US |
49 | 2 |
Blindness, Punctate keratitis, Keratitis, Dyspnoea, Eye irritation, Product use in unapproved indication, Eosinophilic oesophagitis, Dry eye, Eye pain, Asthma, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1412 | 26719107 |
US |
59 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALPRAZOLAM, THYROID, PORCINE, BUDESONIDE, DEXLANSOPRAZOLE, LORATADINE, LORATADINE ORAL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, |
||||
| 1413 | 26719153 |
KR |
87 | 2 |
Asthma, Wheezing, Cough, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 1414 | 26719165 |
US |
57 | 2 |
Fungal infection, Sleep disorder due to a general medical condition, Headache, Asthma, |
||||
DUPILUMAB, |
||||
| 1415 | 26719171 |
US |
8 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1416 | 26719324 |
US |
35 | 1 |
Asthma, Drug effect less than expected, |
||||
DUPILUMAB, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TEZEPELUMAB-EKKO, CETIRIZINE HYDROCHLORIDE, |
||||
| 1417 | 26719450 |
US |
6 | 1 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1418 | 26719556 |
BR |
73 | 1 |
Asthma, Drug ineffective, Device malfunction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1419 | 26719636 |
US |
63 | 2 |
Urinary tract infection, Asthma, Dyspnoea, Chest discomfort, Chest pain, Wheezing, Fatigue, Sleep disorder, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1420 | 26719778 |
US |
48 | 2 |
Diabetes mellitus, Asthma, Product dose omission in error, Drug ineffective, |
||||
DUPILUMAB, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, ROFLUMILAST, |
||||
| 1421 | 26719903 |
US |
2 | |
Hypersensitivity, Nasal disorder, Rash, Asthma, |
||||
DUPILUMAB, |
||||
| 1422 | 26719942 |
2 | ||
Pneumonia, Bronchitis, Syncope, Asthma, |
||||
PIRTOBRUTINIB, |
||||
| 1423 | 26719981 |
US |
70 | 2 |
Asthma, Upper-airway cough syndrome, Cough, |
||||
DUPILUMAB, |
||||
| 1424 | 26719994 |
US |
42 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1425 | 26720031 |
US |
2 | |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1426 | 26720291 |
US |
75 | 1 |
Injection site pain, Respiratory syncytial virus infection, Upper-airway cough syndrome, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CARVEDILOL, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 1427 | 26720790 |
CA |
66 | |
Death, Ageusia, Angina pectoris, Anosmia, Asthma, Asthenia, Back pain, Blood immunoglobulin E increased, Blood pressure systolic increased, Chest discomfort, Chronic obstructive pulmonary disease, Decreased activity, Diabetes mellitus, Dyspnoea, Dyspnoea at rest, Exostosis, FEV1/FVC ratio decreased, Forced expiratory volume decreased, Forced vital capacity decreased, Hepatic cancer, Inspiratory capacity decreased, Neoplasm malignant, Obstructive airways disorder, Pneumonia, Intervertebral disc protrusion, Pulmonary mass, Respiratory distress, Sleep apnoea syndrome, Sleep disorder, Smoke sensitivity, Total lung capacity decreased, Upper-airway cough syndrome, Wheezing, Cough, Fatigue, Product supply issue, Inappropriate schedule of product administration, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, GLYCOPYRROLATE, GLYCOPYRROLATE, PREDNISONE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
| 1428 | 26721252 |
2 | ||
Brain neoplasm, Asthma, Product use issue, Therapy interrupted, |
||||
TEZEPELUMAB-EKKO, FAMOTIDINE, LACOSAMIDE, |
||||
| 1429 | 26721450 |
CN |
61 | 2 |
Asthma, |
||||
| 1430 | 26721520 |
EU |
48 | 2 |
Clostridium difficile colitis, Immune-mediated enterocolitis, Diarrhoea, Pyrexia, C-reactive protein increased, Gingivitis, Rash, Rhinitis, Dyspnoea, Nocturnal dyspnoea, Asthma, Klebsiella urinary tract infection, Pruritus, Hot flush, Neuropathy peripheral, Urinary tract infection, Headache, Musculoskeletal stiffness, Nausea, Diarrhoea, Pruritus, Respiratory tract infection, Abdominal pain upper, Oedema peripheral, Immune-mediated hypothyroidism, Vomiting, Alopecia, Erythema, Diarrhoea, Cystitis noninfective, Herpes zoster, Conjunctivitis, Diaphragmalgia, Stoma site pain, Diarrhoea, Abdominal pain upper, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Diarrhoea, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Abdominal hernia, Food intolerance, Gastrointestinal disorder, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, BISOPROLOL FUMARATE, |
||||
| 1431 | 26726742 |
44 | 2 | |
Total lung capacity decreased, Asthma, Obstructive airways disorder, Tachycardia, Headache, Hypertension, Injection related reaction, Pruritus, Feeling abnormal, Chest discomfort, |
||||
TIRZEPATIDE, |
||||
| 1432 | 26711734 |
US |
1 | |
Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 1433 | 26711774 |
GB |
2 | |
Hospitalisation, Asthma, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 1434 | 26711815 |
CA |
2 | |
Pneumonia, Asthma, Nasopharyngitis, Rhinorrhoea, Cough, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 1435 | 26711856 |
US |
60 | 2 |
Asthma, Dizziness, Dehydration, Off label use, Confusional state, |
||||
IPRATROPIUM BROMIDE AND ALBUTEROL, |
||||
| 1436 | 26711875 |
US |
||
Arthralgia, Rash, Meniscus injury, Asthma, Feeling hot, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 1437 | 26711949 |
CA |
60 | |
Abdominal pain, Adrenal insufficiency, Asthma, Basophil count increased, Carpal tunnel syndrome, Cellulitis, Decreased activity, Dyspnoea, Epiglottitis, Injury, Lung disorder, Ovarian cyst, Oxygen saturation decreased, Pain, Parkinson^s disease, Parkinsonian crisis, Productive cough, Seasonal allergy, Sinus pain, Thyroid disorder, Tremor, Weight decreased, White blood cell count decreased, Bronchitis, Pneumonia, Sepsis, Sinusitis, Weight increased, Cough, Illness, Pyrexia, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, HYDROCORTISONE SODIUM SUCCINATE, MORPHINE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 1438 | 26711971 |
US |
47 | 2 |
Seasonal allergy, Conjunctivitis allergic, Asthma, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, EVOLOCUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1439 | 26712774 |
US |
1 | |
Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1440 | 26712831 |
US |
35 | 2 |
Pneumonia, Asthma, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 1441 | 26713311 |
EU |
66 | 1 |
Neutropenic sepsis, Fibrin D dimer increased, Chest pain, Chills, Pyrexia, Neutropenia, Vitamin D deficiency, Asthma, Leukopenia, Pain, Deep vein thrombosis, Oedema peripheral, Polyneuropathy, Lymphoedema, Drug therapeutic incompatibility, Pulpitis dental, C-reactive protein increased, C-reactive protein increased, C-reactive protein increased, Dizziness, Nausea, Anaemia, Off label use, Product use in unapproved indication, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PEGFILGRASTIM, PEGFILGRASTIM, PEGFILGRASTIM, PEGFILGRASTIM, PEGFILGRASTIM, PEGFILGRASTIM, PEGFILGRASTIM, ACYCLOVIR, ALLOPURINOL, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE, MESNA, MESNA, MESNA, MESNA, MESNA, MESNA, MESNA, MESNA, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, CLEMASTINE FUMARATE, CLEMASTINE FUMARATE, CLEMASTINE FUMARATE, CLEMASTINE FUMARATE, CLEMASTINE FUMARATE, CLEMASTINE FUMARATE, CLEMASTINE FUMARATE, CLEMASTINE FUMARATE, CLEMASTINE FUMARATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1442 | 26713378 |
US |
||
Asthma, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1443 | 26713407 |
US |
46 | 2 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, PREDNISONE, |
||||
| 1444 | 26713420 |
US |
62 | 2 |
COVID-19, Influenza, Asthma, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1445 | 26713581 |
US |
2 | |
Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 1446 | 26713693 |
US |
48 | 2 |
Asthma, Productive cough, Dyspnoea, Loss of personal independence in daily activities, Chest discomfort, |
||||
DUPILUMAB, |
||||
| 1447 | 26713712 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1448 | 26713726 |
US |
36 | 2 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ALPRAZOLAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, GABAPENTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, UMECLIDINIUM, ESCITALOPRAM, |
||||
| 1449 | 26713844 |
US |
74 | 2 |
Asthma, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1450 | 26713851 |
US |
5 | 1 |
Asthma, Pain in extremity, |
||||
DUPILUMAB, |
||||
| 1451 | 26713868 |
US |
75 | 2 |
Nausea, Vomiting, Vocal cord disorder, Seasonal allergy, Dyspnoea, Rash, Asthenia, Fatigue, Emphysema, Chronic obstructive pulmonary disease, Asthma, Nausea, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1452 | 26713945 |
US |
74 | 2 |
Dyspnoea, Lethargy, Swelling, Wheezing, Weight increased, Injection site rash, Asthma, |
||||
DUPILUMAB, |
||||
| 1453 | 26714004 |
US |
57 | 2 |
Dyspnoea, Asthma, |
||||
DUPILUMAB, |
||||
| 1454 | 26714014 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1455 | 26714121 |
US |
36 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1456 | 26714179 |
US |
61 | 2 |
Blood glucose increased, Sinusitis, Fatigue, Sleep disorder, Weight increased, Inability to afford medication, Asthma, Neck pain, Dry eye, Osteoarthritis, Osteopenia, |
||||
METHYLPREDNISOLONE, IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE, METHOCARBAMOL, METHOCARBAMOL TABLETS, AMOXICILLIN AND CLAVULANATE POTASSIUM, FLUCONAZOLE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, SUMATRIPTAN SUCCINATE, PHYTONADIONE, CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, BIOTIN, ERGOCALCIFEROL, VITAMIN C, ESTRADIOL, MONTELUKAST SODIUM, FERROUS SULFATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, NAPROXEN, NAPROXEN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MAGNESIUM, ROSUVASTATIN CALCIUM, FAMOTIDINE, |
||||
| 1457 | 26714223 |
US |
66 | 2 |
Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 1458 | 26714250 |
US |
2 | |
Asthma, Bronchitis, |
||||
DUPILUMAB, |
||||
| 1459 | 26714251 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1460 | 26714335 |
US |
74 | 1 |
Bronchitis, Asthma, |
||||
DUPILUMAB, |
||||
| 1461 | 26714340 |
US |
1 | |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1462 | 26714408 |
US |
82 | 2 |
Respiratory tract congestion, Condition aggravated, Productive cough, Condition aggravated, Product dose omission issue, Cough, Oral candidiasis, Bladder spasm, Dry mouth, Oropharyngeal discomfort, Retching, Asthma, Intentional product use issue, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 1463 | 26714519 |
US |
74 | 1 |
Asthma, Cough, Off label use, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1464 | 26714531 |
US |
67 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1465 | 26714557 |
US |
49 | 2 |
Asthma, Productive cough, Dyspnoea, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1466 | 26714666 |
US |
5 | 2 |
Asthma, Wrong technique in product usage process, Device malfunction, Incorrect dose administered by device, Intentional device misuse, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1467 | 26714677 |
CA |
41 | |
Abdominal discomfort, Abdominal pain, Adverse food reaction, Anxiety, Asthma, Biliary colic, Blood immunoglobulin E abnormal, Blood potassium decreased, Blood pressure increased, Brain fog, Cellulitis, Chest pain, Cholecystitis, Cholelithiasis, Chronic spontaneous urticaria, Concomitant disease aggravated, Condition aggravated, Cyanosis, Diarrhoea, Dizziness, Dysphagia, Dysphonia, Dyspnoea, Epistaxis, Erythema, Fatigue, Fear, Fear of death, Feeling abnormal, Feeling cold, Flushing, Heart rate increased, Insomnia, Laboratory test abnormal, Malaise, Migraine, Nasal disorder, Nausea, Obstructive airways disorder, Pallor, Pneumonia, Post procedural complication, Pruritus, Rash, Rash erythematous, Rash macular, Respiratory tract oedema, Seasonal allergy, Sensitivity to weather change, Sleep deficit, Speech disorder, Stress, Stridor, Tachycardia, Throat irritation, Tremor, Unevaluable event, Vomiting, Urticaria, Anaphylactic reaction, Headache, Hypersensitivity, Illness, Upper respiratory tract infection, Off label use, Therapeutic response shortened, Suspected off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIMENHYDRINATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 1468 | 26714727 |
EU |
40 | 1 |
Dyspnoea, Asthma, Chest discomfort, |
||||
| 1469 | 26715592 |
US |
33 | |
Pneumonia, Asthma, |
||||
UBLITUXIMAB, UBLITUXIMAB, ERGOCALCIFEROL, LEVETIRACETAM, MODAFINIL, MODAFINIL, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 1470 | 26715654 |
US |
||
Asthma, Wrong technique in device usage process, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 1471 | 26717240 |
US |
76 | 1 |
Pneumonia, Asthma, Bronchitis, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1472 | 26717335 |
US |
2 | |
Therapeutic product effect decreased, Asthma, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 1473 | 26717433 |
US |
43 | |
Influenza B virus test positive, Influenza A virus test positive, Parainfluenza virus infection, Asthma, |
||||
RUXOLITINIB, |
||||
| 1474 | 26717555 |
US |
||
Asthma, Incorrect dose administered, Wrong technique in device usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 1475 | 26717693 |
US |
2 | |
Immunodeficiency, Pneumonia bacterial, Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1476 | 26717694 |
US |
1 | |
Pneumonia, Asthma, Bronchitis, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1477 | 26704784 |
CA |
60 | |
Asthma, Cough, Disease recurrence, Drug dependence, Dyspnoea, Eosinophil count increased, Eosinophilic granulomatosis with polyangiitis, Full blood count abnormal, Gastrooesophageal reflux disease, Haemoptysis, Hypoaesthesia, Malaise, Neuropathy peripheral, Paraesthesia, Productive cough, Vasculitis, Product use in unapproved indication, Visual impairment, Therapeutic product effect incomplete, Upper respiratory tract infection, |
||||
BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GLYCOPYRROLATE, AZATHIOPRINE, MOMETASONE FUROATE, MOMETASONE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, MOMETASONE FUROATE, FLUTICASONE PROPIONATE, ROSUVASTATIN, ROSUVASTATIN, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, GLYCOPYRROLATE, RANIBIZUMAB, MOMETASONE, |
||||
| 1478 | 26704870 |
|||
Asthma, Pruritus, Dry eye, Eye pruritus, Loss of personal independence in daily activities, |
||||
CERTOLIZUMAB PEGOL, ALBUTEROL SULFATE, CELECOXIB, DULOXETINE HYDROCHLORIDE, DULOXETINE, DUPILUMAB, EPINEPHRINE, ADRENALINUM, FLUTICASONE PROPIONATE, FOLIC ACID, METHOTREXATE SODIUM, MONTELUKAST SODIUM, MONTELUKAST, EPINEPHRINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FAMOTIDINE, PREGABALIN, ALBUTEROL SULFATE, DENOSUMAB, ROSUVASTATIN CALCIUM, VITAMIN C, FLUTICASONE PROPIONATE AND SALMETEROL, ALPRAZOLAM, |
||||
| 1479 | 26705184 |
CA |
||
Impaired quality of life, Loss of personal independence in daily activities, Asthma, Dyspnoea, Wheezing, Sleep disorder due to a general medical condition, Myocardial infarction, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, ACLIDINIUM BROMIDE, ACLIDINIUM BROMIDE, FLUTICASONE FUROATE, PREDNISONE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
| 1480 | 26705226 |
CA |
46 | |
Asthma, Dust allergy, Dyspnoea, Fall, Asthenia, Back pain, Bronchitis, COVID-19, Exercise tolerance decreased, Eyelid oedema, Facial pain, Feeling abnormal, Fibromyalgia, Influenza, Loss of consciousness, Pain, Pain in extremity, Pneumonia, Productive cough, Pulmonary congestion, Shock, Skin lesion, Sputum discoloured, Swelling, Temperature intolerance, Terminal insomnia, Weight decreased, Arthralgia, Fatigue, Pruritus, Syncope, Urticaria, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CANDESARTAN CILEXETIL, MONTELUKAST SODIUM, LEVOTHYROXINE SODIUM, |
||||
| 1481 | 26705259 |
CA |
47 | |
Asthma, Blood immunoglobulin E increased, Chest discomfort, Dyspnoea, Eye pruritus, Hyperhidrosis, Nephrolithiasis, Obstructive airways disorder, Pancreatic disorder, Viral infection, Pneumonia respiratory syncytial viral, Wheezing, Dizziness, Pruritus, Urticaria, Product dose omission issue, |
||||
OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, METOCLOPRAMIDE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, |
||||
| 1482 | 26705403 |
US |
2 | |
Asthma, Product dose omission issue, Device delivery system issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 1483 | 26705419 |
US |
64 | 1 |
Hospitalisation, Asthma, Sleep disorder, General physical health deterioration, Secretion discharge, Tremor, Restless legs syndrome, Vision blurred, Loss of personal independence in daily activities, Sputum discoloured, Back pain, Muscle spasms, Dyspnoea exertional, Sputum increased, Musculoskeletal chest pain, Cough, Dyspnoea, Productive cough, Fatigue, Nausea, Chest discomfort, Adverse drug reaction, Therapy interrupted, |
||||
ALBUTEROL SULFATE, ALBUTEROL, AMIKACIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 1484 | 26705439 |
US |
70 | 2 |
Chronic obstructive pulmonary disease, Asthma, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1485 | 26705442 |
US |
67 | 2 |
Pneumonia, Asthma, |
||||
DUPILUMAB, |
||||
| 1486 | 26705466 |
US |
53 | 2 |
Pneumonia, Bronchiectasis, Influenza, Pyrexia, Chills, Headache, Dizziness, Respiratory tract inflammation, Cough, Oxygen saturation decreased, Dyspnoea, Upper-airway cough syndrome, Oropharyngeal pain, Dysphonia, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1487 | 26705472 |
US |
64 | 2 |
Pneumonia, Asthma, Malaise, Headache, Nausea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1488 | 26705482 |
US |
2 | |
Asthma, Breath sounds abnormal, Bronchitis, |
||||
DUPILUMAB, |
||||
| 1489 | 26705521 |
US |
57 | 2 |
Macular degeneration, Hip arthroplasty, Asthma, Chronic obstructive pulmonary disease, Emphysema, Ehlers-Danlos syndrome, Anxiety, |
||||
DUPILUMAB, LORATADINE, LORATADINE TABLET, ROSUVASTATIN, DEXLANSOPRAZOLE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DULOXETINE HYDROCHLORIDE, DULOXETINE, EPINEPHRINE, CRISABOROLE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE, CLONAZEPAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LOSARTAN POTASSIUM, LOSARTAN, PREGABALIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NITROGLYCERIN, ONDANSETRON HYDROCHLORIDE, OXYGEN, 0XYGEN, FAMOTIDINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, CYCLOSPORINE, MONTELUKAST SODIUM, TOLTERODINE TARTRATE, TOLTERODINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, VITAMIN E, |
||||
| 1490 | 26705601 |
US |
2 | |
Asthma, Product use issue, Product dose omission issue, Device delivery system issue, Product cleaning inadequate, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 1491 | 26705636 |
CA |
71 | 2 |
Discomfort, Eructation, Constipation, Asthma, Dysphonia, Respiratory tract infection, Discomfort, Fatigue, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, |
||||
| 1492 | 26707852 |
US |
2 | |
Asthma, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, MONTELUKAST SODIUM, |
||||
| 1493 | 26707936 |
US |
58 | 2 |
COVID-19, Dyspnoea, Asthma, Middle insomnia, Oxygen saturation decreased, Injection site pain, Chest discomfort, Therapeutic response shortened, Product preparation issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1494 | 26707961 |
US |
3 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1495 | 26708052 |
US |
44 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1496 | 26708063 |
US |
34 | 1 |
Asthma, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 1497 | 26708142 |
CA |
65 | |
Asthma, Chest pain, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Vomiting, Wheezing, Drug hypersensitivity, Cough, Pneumonia, Respiratory tract infection, |
||||
OMALIZUMAB, OMALIZUMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, AMLODIPINE BESYLATE, CALCIUM, CALCIUM, CALCIUM CARBONATE, ANTACID, CEFADROXIL, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, ROSUVASTATIN, ROSUVASTATIN, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, POLYMYXIN B SULFATE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 1498 | 26708175 |
US |
60 | 1 |
Irritability, Asthma, Productive cough, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1499 | 26708223 |
CA |
62 | |
Asthma, Blood pressure increased, Blood pressure systolic decreased, Blood pressure systolic increased, Bronchitis, Chest discomfort, Dysphonia, Dyspnoea, Eye pruritus, Forced expiratory volume decreased, Frustration tolerance decreased, Heart rate increased, Hypopnoea, Lower respiratory tract infection, Middle insomnia, Nasal congestion, Nasal discharge discolouration, Nasopharyngitis, Oropharyngeal pain, Productive cough, Rhinorrhoea, Vomiting, Wheezing, Cough, Diarrhoea, Headache, Nausea, Pyrexia, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, |
||||
| 1500 | 26708235 |
US |
64 | 1 |
Asthma, Sinusitis, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30